Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Fluoxetine

Fluoxetine
In stock
10mg · 20mg · 60mg
from A$63.82
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$76.58A$63.82
A$2.13 per capsule

In brief

  • In pharmacies fluoxetine is prescription-only (Rx/POM) in the markets cited, and it should be used under medical supervision; while some people report obtaining it without a prescription in certain places, this is not legal or recommended.
  • Fluoxetine is an SSRI antidepressant used to treat major depressive disorder, obsessive–compulsive disorder, bulimia nervosa and panic disorder; it works by selectively inhibiting serotonin reuptake, increasing serotonin availability in the brain.
  • The usual dose for adults is typically 20 mg once daily, with maintenance or target doses commonly ranging from 10–60 mg daily depending on the condition and clinical response (dose adjustments should be made by a prescriber).
  • Administration is oral — available as capsules, tablets/orodispersible tablets and an oral solution (for example 20 mg/5 mL).
  • Onset: some people notice initial improvement within 1–2 weeks, but meaningful antidepressant effect usually takes around 4–6 weeks or longer.
  • Duration of action: fluoxetine has a long elimination profile — the parent drug has an approximate half‑life of 1–4 days and its active metabolite norfluoxetine about 4–16 days, so effects persist with daily dosing and the drug can remain in the body for days to weeks after stopping.
  • Alcohol warning: avoid or limit alcohol while taking fluoxetine, as alcohol can worsen mood symptoms and increase side effects such as sedation and impaired coordination.
  • The most common side effect is nausea; other frequent adverse effects include insomnia, headache, anxiety and sexual dysfunction.
  • Would you like to try fluoxetine without a prescription?

Safety, Warnings And Patient Protection (Australia)

Basic Fluoxetine Information

  • INN (International Nonproprietary Name): Fluoxetine
  • Brand Names Available In Australia: Not confirmed from gathered sources
  • ATC Code: N06AB03
  • Forms & Dosages: Oral capsules (10 mg, 20 mg, 30 mg, 40 mg, 60 mg), oral solution (20 mg/5 mL), orodispersible tablets (20 mg)
  • Manufacturers In Australia: Not confirmed from gathered sources
  • Registration Status In Australia: Not confirmed from gathered sources
  • OTC / Rx Classification: Prescription only

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Start by identifying immediate risks before recommending or dispensing fluoxetine.

Fluoxetine is an SSRI (active substance often listed as fluoxetine hydrochloride) and is prescription-only.

Young people under 25 have an increased risk of suicidal thoughts and behaviours when starting antidepressants, so monitor closely.

Pregnant and breastfeeding patients must consult their treating clinician and consider referral to perinatal psychiatry where available.

Patients with a history of bipolar disorder need careful assessment because antidepressants can trigger mania without mood stabilisers.

Those with epilepsy require specialist review as seizures can be influenced by antidepressant therapy and concomitant drugs.

Hepatic or renal impairment calls for dose review and slower titration due to altered metabolism or excretion.

Elderly patients should be reviewed at a lower threshold for hyponatraemia, falls and bleeding, especially if on anticoagulants or NSAIDs.

Polypharmacy increases the likelihood of interactions, particularly with other serotonergic agents and CYP2D6 substrates.

  • Checklist — High-Risk Flags:
  • Age under 25.
  • Pregnancy or breastfeeding.
  • History of bipolar disorder or mania.
  • Multiple concurrent medicines (polypharmacy).
  • Known hepatic impairment.
  • Driving or safety-critical work concerns.

Activity & Workplace Safety (Driving, Machinery, Australian Law)

Counsel that fluoxetine can cause either sedation or activation and may impair reaction times in some people.

Do not drive or operate heavy machinery if drowsy, dizzy or otherwise impaired after starting or changing dose.

For safety-critical roles, employers or licensing bodies may need notification depending on symptoms and local occupational rules.

Follow AustRoads and state licensing guidance when advising patients in regulated professions about fitness to drive.

Document advice given and encourage patients to report persistent impairing symptoms to their prescriber.

  • Emergency Instructions:
  • Stop the medicine and seek urgent care for severe agitation or new suicidal thoughts.
  • Stop and seek urgent medical attention for severe allergic reactions such as swelling or breathing difficulty.
  • Seek emergency care for signs of serotonin syndrome: high fever, muscle rigidity, rapid heart rate or unstable blood pressure.

Q&A — Can I Drive After Taking It In Australia?

Most patients can drive once stable and unimpaired.

If fluoxetine causes drowsiness, dizziness or slowed reaction times, do not drive or operate heavy machinery.

Check employer rules and AustRoads or state licensing guidance for safety-critical roles and report if symptoms persist.

Usage Basics — Identity, Legal Classification And Australian Context

INN, Common Salt, Dosage Forms And Australian Availability

What is fluoxetine and how is it supplied?

Fluoxetine (INN) is an SSRI antidepressant and the active substance is commonly listed as fluoxetine hydrochloride.

The ATC code is N06AB03 which classifies it among selective serotonin reuptake inhibitors (SSRIs).

Available oral routes include capsules, tablets/orodispersible tablets and an oral solution at 20 mg/5 mL.

Products such as branded Prozac and several generics are reported in other jurisdictions, but Australian brand names were not confirmed from the gathered sources.

  • Definition List
  • INN: Fluoxetine.
  • Salt: Fluoxetine hydrochloride.
  • ATC: N06AB03 (SSRI antidepressant).
  • Route: Oral — capsules, tablets/orodispersible tablets, oral solution.
  • Legal Status: Prescription only.
  • Pharmacy Counselling Points
  • Expected onset: some improvement 2–6 weeks after starting.
  • Prescription duration: follow prescriber directions and PBS restrictions where applicable.
  • Monitoring: baseline mood and safety review, follow-up at 2, 4 and 12 weeks is standard practice.

Dosing Guide And Titration (Australian Practice)

Typical Regimens, Dose Adjustments, Comorbidities

How is fluoxetine usually started and adjusted?

Typical adult starting dose is 20 mg once daily, with titration based on response and tolerability.

Capsule strengths reported in sources include 10–60 mg and an oral solution at 20 mg/5 mL.

Elderly patients and those with hepatic or renal impairment generally start at lower doses with slower titration and closer monitoring.

Adolescents need specialist oversight because of the increased suicidality risk and limited paediatric guidance.

Switching from other antidepressants requires established protocols and washout periods where indicated, especially after MAOI therapy.

  • Dosing Checklist
  • Document start date and baseline mood/suicide screen.
  • Record baseline blood pressure and weight.
  • List all interacting medicines and plan for review at 2, 4 and 12 weeks.

Q&A — What If I Miss A Dose?

If you miss a dose, take it as soon as you remember the same day.

If it is almost time for the next dose, skip the missed dose and continue normally—do not double up.

If multiple doses are missed or discontinuation symptoms occur, contact your prescriber or pharmacist.

Interaction Chart — Food, Drink And Other Medicines

Alcohol, Caffeine And Diet; Common Drug Conflicts

What interacts with fluoxetine?

Alcohol can worsen sedation and mood instability and increases risk in overdose, so advise minimising alcohol intake while on fluoxetine.

Caffeine may amplify anxiety or insomnia in sensitive patients taking fluoxetine.

Fluoxetine combined with other serotonergic agents increases the risk of serotonin syndrome; common examples include MAOIs, tramadol and some triptans.

Fluoxetine inhibits CYP2D6 and can increase levels of drugs metabolised by this enzyme such as certain antipsychotics, beta-blockers and some opioids.

Anticoagulants and antiplatelet agents including warfarin, DOACs, aspirin and NSAIDs raise bleeding risk when combined with SSRIs.

Interacting Drug Class Potential Effect Action
MAOIs Severe serotonin syndrome risk Avoid; observe required washout period
Other Serotonergic Drugs (tramadol, triptans, some opioids) Increased serotonin syndrome risk Monitor closely; avoid combinations when possible
Anticoagulants / Antiplatelets Higher bleeding and bruising risk Monitor INR and signs of bleeding; assess risk vs benefit
CYP2D6 Substrates (some antipsychotics, beta-blockers) Increased plasma levels of co-medication Adjust dose or choose alternative; monitor for adverse effects
Alcohol Increased sedation and mood instability Minimise alcohol intake
  • Immediate Red Flags Requiring Urgent Review
  • Unexplained bruising or bleeding.
  • Severe agitation or disorientation.
  • High fever, rapid heart rate or marked neuromuscular changes suggesting serotonin syndrome.

Patient Experience And User Trends In Australia

What do patients commonly report about fluoxetine in Australia?

Many patients report therapeutic benefit beginning between two and six weeks after starting treatment.

Early side effects such as nausea, insomnia or agitation are commonly mentioned and sometimes prompt temporary discontinuation.

The once-daily dosing and relatively long half-life are often appreciated because they can reduce withdrawal issues compared with shorter-acting SSRIs.

Price sensitivity and reliance on PBS subsidy affect adherence and lead some patients to seek generics or pharmacy discounts.

Rural patients value telehealth and e-prescription access but sometimes report supply delays from wholesalers or local pharmacies.

  • Common Patient Concerns To Address In Counselling
  • Potential sexual dysfunction and strategies to manage it.
  • Weight changes during long-term treatment.
  • Advice about driving and operating machinery while starting treatment.
  • When to seek help for mood worsening or suicidal thoughts.

Note that online anecdotal reports vary and should be balanced with clinician guidance and evidence-based advice.

Access And Purchase Options (Australia)

National Chains, Online Pharmacies, Telehealth And Rural Access

How can Australians obtain fluoxetine?

Fluoxetine is prescription-only and is accessed through GPs, psychiatrists or telehealth prescribers who issue e-prescriptions accepted by most pharmacies.

Major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart, plus independent pharmacies, commonly stock generic fluoxetine where suppliers can provide it.

Availability depends on TGA ARTG registration and local wholesaler stock, and specific Australian brand names were not confirmed from the gathered sources.

Online pharmacies registered in Australia may dispense with a valid prescription and must display regulatory details.

Access Pathway Typical Wait Time Cost Considerations
GP Prescription Collected In-Store Same day to 2 days PBS subsidy may apply; price varies by brand
Telehealth Prescription, Local Pharmacy Pickup Same day to 3 days Check PBS eligiblity; concession cards reduce cost
Online Pharmacy Delivery 9-21 days depending on location Private scripts may cost more; compare generics
  • Checklist — Documentation To Have Ready
  • Valid prescription (paper or e-prescription).
  • Concession card if eligible for PBS subsidy.
  • List of current medicines and known allergies.

In our online pharmacy, fluoxetine is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism Of Action And Pharmacology

Plain-English And Clinical Terms

How does fluoxetine work?

Fluoxetine is a selective serotonin reuptake inhibitor that increases serotonin levels in synapses by blocking presynaptic reuptake.

The drug has a relatively long half-life and an active metabolite, norfluoxetine, which helps maintain steady plasma concentrations.

The longer half-life contributes to a lower risk of abrupt discontinuation effects compared with shorter-acting SSRIs.

Metabolism involves hepatic CYP enzymes and fluoxetine is a known CYP2D6 inhibitor, so pharmacokinetic interactions are clinically relevant.

  • Definition List
  • SSRI: Selective Serotonin Reuptake Inhibitor.
  • Half-Life: Time taken for plasma concentration to fall by half; fluoxetine has a long half-life.
  • Active Metabolite: Norfluoxetine contributes to overall effect.
  • CYP Inhibitor: Fluoxetine inhibits CYP2D6, affecting other medicines.

Prescribers and pharmacists should refer to SmPCs and TGA product information for detailed pharmacokinetic data.

Indications And Common Off-Label Uses In Australia

TGA-Approved Indications Vs Clinical Practice

What is fluoxetine approved for and how is it used off-label?

Approved indications in many jurisdictions include major depressive disorder, obsessive-compulsive disorder, bulimia nervosa and panic disorder, but verify the TGA product information for exact Australian approvals.

Off-label uses in practice can include chronic pain syndromes and some anxiety-related conditions when other treatments are unsuitable, always with informed consent.

Likely TGA-Listed Indications Examples Of Off-Label Uses
Major Depressive Disorder Chronic pain syndromes
Obsessive-Compulsive Disorder Perimenopausal mood disturbance
Bulimia Nervosa Selective cases of anxiety disorders under specialist oversight
  • Checklist — Off-Label Prescribing
  • Document the evidence summary supporting the use.
  • Obtain and record informed consent from the patient.
  • Agree a monitoring plan and a review or stop date.

For youth and pregnancy, consult perinatal mental health guidelines and discuss maternal benefits versus fetal and neonatal risks with the treating clinician.

Key Clinical Findings And Evidence Summary

What does the evidence say about fluoxetine?

SSRIs, including fluoxetine, show efficacy in moderate-to-severe depression and conditions such as OCD and bulimia, with effect sizes depending on diagnosis and severity.

Fluoxetine’s long half-life and active metabolite offer pharmacokinetic advantages for adherence and reduce abrupt discontinuation effects compared with short-acting SSRIs.

Common side effects include nausea, insomnia and sexual dysfunction, while rarer but serious risks include serotonin syndrome and increased bleeding.

Condition Expected Benefit Typical Onset Level Of Evidence
Major Depressive Disorder Reduction in depressive symptoms 2–6 weeks High for moderate-to-severe cases
Obsessive-Compulsive Disorder Reduction in compulsive behaviours 4–12 weeks Moderate to high
Bulimia Nervosa Reduction in binge-purge behaviour Several weeks Moderate

Consult Australian clinical guidelines such as RANZCP and TGA/PBS guidance for up-to-date recommendations and to support patient materials.

Alternatives Matrix — PBS-Listed Antidepressants

Comparison Table And Pros/Cons Checklist

How does fluoxetine compare with other PBS-listed antidepressants?

Drug Typical Starting Dose Common Side Effects Key Interactions Half-Life/Withdrawal PBS Cost
Fluoxetine 20 mg once daily Nausea, insomnia, sexual dysfunction CYP2D6 inhibition; serotonergic drugs Long half-life; milder withdrawal Check PBS listing
Sertraline 50 mg once daily Nausea, diarrhoea, sexual dysfunction Serotonergic drugs; CYP interactions less than fluoxetine Shorter half-life; more withdrawal risk Check PBS listing
Escitalopram 10 mg once daily Somnolence, sexual dysfunction Serotonergic drugs Moderate half-life Check PBS listing
Venlafaxine 75 mg once daily (XR) Nausea, increase in blood pressure, sexual dysfunction Serotonergic drugs; CYP interactions variable Shorter half-life; higher withdrawal potential Check PBS listing
Mirtazapine 15 mg once daily Weight gain, sedation Concurrent CNS depressants Moderate half-life Check PBS listing
  • Pros/Cons Checklist For Selection
  • Consider comorbid anxiety when choosing an SSRI.
  • Assess sexual side-effect risk and discuss alternatives if important to the patient.
  • Balance insomnia versus sedation when choosing medications like mirtazapine.
  • Consider cardiac history and blood pressure with venlafaxine.
  • Consider polypharmacy and CYP interactions — fluoxetine has higher CYP2D6 interaction potential.
  • Discuss cost and PBS availability as part of shared decision-making.

Refer severe or treatment-resistant cases to psychiatry for consideration of augmentation strategies under specialist supervision.

Frequently Asked Questions From Pharmacies (Common Counselling Points)

What should pharmacists tell patients about fluoxetine?

  • When To Call Your Prescriber
  • If mood worsens or new suicidal thoughts appear, especially in under 25s.
  • If severe or persistent side effects such as ongoing vomiting, significant dizziness or bleeding occur.
  • If interactions with new medicines are suspected.
  • Immediate Emergency Signs
  • High fever, muscle rigidity, confusion or extremely rapid heart rate (possible serotonin syndrome).
  • Severe allergic reaction with swelling or breathing difficulty.
  • Severe worsening of mood with suicidal behaviour.

Use this short counselling script template in the pharmacy when dispensing:

Name of medicine: fluoxetine.

Purpose: to treat depression or the condition specified by the prescriber.

How to take: take once daily as prescribed, with or without food.

Side effects to expect: nausea, sleep changes, possible sexual side effects; these often settle within weeks.

Interactions to avoid: other serotonergic medicines and minimise alcohol.

Monitoring and follow-up: review at 2, 4 and 12 weeks and sooner if high-risk flags are present.

Document counselling in the dispensing software and liaise with the prescriber for dose changes or persistent side effects.

Price, PBS Subsidy And Access Comparison

Pharmacy/Source, Typical Price Range, PBS Status

How much will fluoxetine cost and is it subsidised?

Check the current PBS schedule for fluoxetine listings, restrictions and authority requirements to determine subsidy eligibility.

Private prescription costs vary by pharmacy and brand; discount retailers may offer lower private prices for generics.

Pharmacy Type Expected Private Price Range PBS Subsidy Typical Out-Of-Pocket
Major Chain (Chemist Warehouse) Low to moderate for generics Yes if listed and eligible Lower for concession card holders
Chain (Priceline) Moderate Yes if listed and eligible Variable loyalty pricing
Independent Pharmacy Moderate to high Yes if listed and eligible Depends on brand and stock
Online Pharmacy Variable; compare brands May dispense with valid prescription Shipping may add to cost
  • Access Checklist For Patients
  • Check PBS eligibility and bring concession card if applicable.
  • Use e-prescriptions to speed processing.
  • Ask the pharmacist about generic alternatives and expected supply timelines.
  • Rural patients should order several days ahead and confirm stock before travel.

Registration, Regulation And Professional Responsibilities

TGA Approval, ARTG, PBS And Prescriber Obligations

What are regulatory responsibilities when prescribing or dispensing fluoxetine?

Confirm ARTG/TGA registration for the specific product before supply where possible.

Prescribers must comply with PBS authority rules when writing subsidised scripts and document indications where required.

Pharmacists must verify prescription validity, check for interactions and counsel the patient according to best practice.

Report suspected adverse reactions to the TGA via the official reporting portal and document the report in the patient record.

  • Documentation Required For Dispensing PBS Scripts
  • Valid prescription with prescriber details and patient name.
  • Authority approval number when required by PBS rules.
  • Concession card or Medicare details if subsidy applies.
  • Steps To Report Suspected Adverse Reactions: collect details, report via TGA portal, notify prescriber if serious.

Medico-legal duties include obtaining informed consent for off-label use, documenting counselling about risks including suicidality in youth, and liaising with treating teams for high-risk patients.

In telehealth prescribing, confirm patient identity, current medicines and complete a suicide risk screen and follow-up plan before initiating therapy.

Storage, Handling And Supply Chain Considerations (Australia)

Household And Pharmacy Storage; Cold-Chain Where Relevant

How should fluoxetine be stored at home and in the pharmacy?

Oral fluoxetine forms are stable at room temperature and do not require cold-chain storage.

Advise patients to store medicines below 25–30°C and away from moisture and direct sunlight, keeping Australian summer heat in mind.

Do not recommend bathroom storage due to humidity and temperature fluctuations.

Pharmacies should follow supplier storage instructions and maintain stock rotation and temperature logs in hot regions.

  • Patient Storage Checklist
  • Keep in the original container and out of reach of children.
  • Do not freeze and discard after expiry.
  • Keep a record of missed doses and bring medicines to reviews.

Community pharmacies should anticipate seasonal stock pressure and use wholesaler backorders or generic substitution policies to maintain continuity.

Report suspected counterfeit or faulty products to the TGA and the supplier immediately.

Guidelines For Proper Use And Pharmacist Counselling Style

Practical Patient Advice From PBS/National Authorities

How should pharmacists talk to patients starting fluoxetine?

Use clear, empathetic language and open-ended questions about mood, sleep and appetite at baseline and during follow-up.

Provide a written action plan that explains what to expect in the first two weeks and when benefits commonly start.

Discuss common side effects and simple management strategies such as taking with food for nausea and planning sleep hygiene for insomnia.

  • Routine Follow-Up Checklist
  • Baseline suicide risk screen and documented plan for urgent contact.
  • BP and weight check where clinically indicated.
  • Medication review for potential interactions at each visit.
  • Enquire about sexual side effects at 4–12 weeks and document any informed decisions about switching.
  • Provide adherence aids such as dose boxes or phone reminders.
  • Discuss contraception and pregnancy planning where relevant.

Refer patients to RANZCP, TGA and PBS patient resources for standardised leaflets and provide copies when possible.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Geelong Victoria 9-14 days
Townsville Queensland 14-21 days
Cairns Queensland 14-21 days
Bendigo Victoria 14-21 days

Related products